刚刚!PD-L1 皮下注射剂在国内获批上市

丁香园肿瘤时间
Nov 14

11 月 14 日,NMPA 官网显示,罗氏制药 PD-L1 单抗阿替利珠单抗皮下注射剂在国内获批上市。Insight 数据库显示,这是首个在国内获批的进口 PD-(L)1 皮下注射剂。不仅如此,之前在英国获批时,该药也是海外最早获批的一款 PD-(L)1 皮下注射剂。截图来源:NMPA 官网阿替利珠单抗是一种靶向 PD-L1 的单克隆抗体,自 2016 年在美国获批以来,该药已经获批超过 10 ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10